MedTrace Logo

Benchmarking Management of Glaucoma Using the Diopsys VEP/PERG Protocols.

NCT02594280 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2018-01-25

No results posted yet for this study

Summary

Establish electrophysiological benchmarks, using the Diopsys Visual Evoked Potential/ Pattern ERG (VEP/PERG) protocols of populations with Glaucoma following: 1) Baseline VEP/ERG prior to treatment; and 2) VEP/PERG after treatment.

Conditions

Sponsors & Collaborators

  • University of Pittsburgh

    collaborator OTHER

  • Diopsys, Inc.

    lead INDUSTRY

Principal Investigators

  • Wollstein Gadi, MD · University of Pittsburgh

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-15
Primary Completion
2018-12-15
Completion
2019-05-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02594280 on ClinicalTrials.gov